Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: Role of precore stop mutants

Young Nyun Park, Kwang Hyub Han, Kyung Sup Kim, Jun Pyo Chung, Seungtaek Kim, Chanil Park

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Aims/Background: The cytoplasmic expression of HBcAg is a possible target of immune hepatocytolysis and it is important for the pathogenesis of hepatic injury in chronic hepatitis B virus (HBV) infection. Cytoplasmic HBcAg expression has been suggested to be related to the precore sequence of HBV, HBV DNA level or cell cycle of hepatocytes and the aim of this study was to understand its mechanism. Material/Methods: We studied the expression pattern of HBcAg and its relationship to serum HBV DNA levels, cell proliferation activity of hepatocytes and precore mutation using 66 patients' sera and biopsied liver specimens of chronic hepatitis B. Results: The expression patterns of HBcAg were cytoplasmic predominant (CP) in 17 cases, nuclear and cytoplasmic (NC) in 10 cases and nuclear predominant (NP) in 9 cases and negative in 30 cases. CP expression cases showed a higher grade of hepatitis activity than NP expression cases. Serum HBV DNA levels showed a wide range and there was no significant difference according to the expression pattern of HBcAg. Cell proliferation activity of hepatocytes, measured by Ki-67 (MIB-1) labelling index was higher in CP expression cases than in NP expression cases and it was also significantly higher in cases of high grade than in low grade hepatitis activity. The precore region was evaluated by primer extension assay in 51 cases and there were 16 cases of 1896 precore mutant, 23 cases of wild type, 12 cases of mixed infection of 1896 precore mutant type and wild type. CP expression of HBcAg was significantly more frequent in 1896 precore mutant cases (86%) than in wild type cases (26%). Conclusion: CP expression of HBcAg is the major pattern of 1896 precore mutant cases and it might be involved in the severe liver injury of precore mutants. One of the mechanisms regulating CP HBcAg expression is suggested to be precore mutation of HBV as well as cell cycle of hepatocyte.

Original languageEnglish
Pages (from-to)199-205
Number of pages7
JournalLiver
Volume19
Issue number3
DOIs
Publication statusPublished - 1999 Jun 16

Fingerprint

Hepatitis B Core Antigens
Chronic Hepatitis B
Virus Diseases
Hepatitis B virus
Hepatocytes
Hepatitis
Liver
DNA
Cell Cycle
Serum
Cell Proliferation
Mutation
Wounds and Injuries
Coinfection
B-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Hepatology

Cite this

Park, Young Nyun ; Han, Kwang Hyub ; Kim, Kyung Sup ; Chung, Jun Pyo ; Kim, Seungtaek ; Park, Chanil. / Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection : Role of precore stop mutants. In: Liver. 1999 ; Vol. 19, No. 3. pp. 199-205.
@article{24a58decddee410d9d753f689321102d,
title = "Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: Role of precore stop mutants",
abstract = "Aims/Background: The cytoplasmic expression of HBcAg is a possible target of immune hepatocytolysis and it is important for the pathogenesis of hepatic injury in chronic hepatitis B virus (HBV) infection. Cytoplasmic HBcAg expression has been suggested to be related to the precore sequence of HBV, HBV DNA level or cell cycle of hepatocytes and the aim of this study was to understand its mechanism. Material/Methods: We studied the expression pattern of HBcAg and its relationship to serum HBV DNA levels, cell proliferation activity of hepatocytes and precore mutation using 66 patients' sera and biopsied liver specimens of chronic hepatitis B. Results: The expression patterns of HBcAg were cytoplasmic predominant (CP) in 17 cases, nuclear and cytoplasmic (NC) in 10 cases and nuclear predominant (NP) in 9 cases and negative in 30 cases. CP expression cases showed a higher grade of hepatitis activity than NP expression cases. Serum HBV DNA levels showed a wide range and there was no significant difference according to the expression pattern of HBcAg. Cell proliferation activity of hepatocytes, measured by Ki-67 (MIB-1) labelling index was higher in CP expression cases than in NP expression cases and it was also significantly higher in cases of high grade than in low grade hepatitis activity. The precore region was evaluated by primer extension assay in 51 cases and there were 16 cases of 1896 precore mutant, 23 cases of wild type, 12 cases of mixed infection of 1896 precore mutant type and wild type. CP expression of HBcAg was significantly more frequent in 1896 precore mutant cases (86{\%}) than in wild type cases (26{\%}). Conclusion: CP expression of HBcAg is the major pattern of 1896 precore mutant cases and it might be involved in the severe liver injury of precore mutants. One of the mechanisms regulating CP HBcAg expression is suggested to be precore mutation of HBV as well as cell cycle of hepatocyte.",
author = "Park, {Young Nyun} and Han, {Kwang Hyub} and Kim, {Kyung Sup} and Chung, {Jun Pyo} and Seungtaek Kim and Chanil Park",
year = "1999",
month = "6",
day = "16",
doi = "10.1111/j.1478-3231.1999.tb00036.x",
language = "English",
volume = "19",
pages = "199--205",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "3",

}

Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection : Role of precore stop mutants. / Park, Young Nyun; Han, Kwang Hyub; Kim, Kyung Sup; Chung, Jun Pyo; Kim, Seungtaek; Park, Chanil.

In: Liver, Vol. 19, No. 3, 16.06.1999, p. 199-205.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection

T2 - Role of precore stop mutants

AU - Park, Young Nyun

AU - Han, Kwang Hyub

AU - Kim, Kyung Sup

AU - Chung, Jun Pyo

AU - Kim, Seungtaek

AU - Park, Chanil

PY - 1999/6/16

Y1 - 1999/6/16

N2 - Aims/Background: The cytoplasmic expression of HBcAg is a possible target of immune hepatocytolysis and it is important for the pathogenesis of hepatic injury in chronic hepatitis B virus (HBV) infection. Cytoplasmic HBcAg expression has been suggested to be related to the precore sequence of HBV, HBV DNA level or cell cycle of hepatocytes and the aim of this study was to understand its mechanism. Material/Methods: We studied the expression pattern of HBcAg and its relationship to serum HBV DNA levels, cell proliferation activity of hepatocytes and precore mutation using 66 patients' sera and biopsied liver specimens of chronic hepatitis B. Results: The expression patterns of HBcAg were cytoplasmic predominant (CP) in 17 cases, nuclear and cytoplasmic (NC) in 10 cases and nuclear predominant (NP) in 9 cases and negative in 30 cases. CP expression cases showed a higher grade of hepatitis activity than NP expression cases. Serum HBV DNA levels showed a wide range and there was no significant difference according to the expression pattern of HBcAg. Cell proliferation activity of hepatocytes, measured by Ki-67 (MIB-1) labelling index was higher in CP expression cases than in NP expression cases and it was also significantly higher in cases of high grade than in low grade hepatitis activity. The precore region was evaluated by primer extension assay in 51 cases and there were 16 cases of 1896 precore mutant, 23 cases of wild type, 12 cases of mixed infection of 1896 precore mutant type and wild type. CP expression of HBcAg was significantly more frequent in 1896 precore mutant cases (86%) than in wild type cases (26%). Conclusion: CP expression of HBcAg is the major pattern of 1896 precore mutant cases and it might be involved in the severe liver injury of precore mutants. One of the mechanisms regulating CP HBcAg expression is suggested to be precore mutation of HBV as well as cell cycle of hepatocyte.

AB - Aims/Background: The cytoplasmic expression of HBcAg is a possible target of immune hepatocytolysis and it is important for the pathogenesis of hepatic injury in chronic hepatitis B virus (HBV) infection. Cytoplasmic HBcAg expression has been suggested to be related to the precore sequence of HBV, HBV DNA level or cell cycle of hepatocytes and the aim of this study was to understand its mechanism. Material/Methods: We studied the expression pattern of HBcAg and its relationship to serum HBV DNA levels, cell proliferation activity of hepatocytes and precore mutation using 66 patients' sera and biopsied liver specimens of chronic hepatitis B. Results: The expression patterns of HBcAg were cytoplasmic predominant (CP) in 17 cases, nuclear and cytoplasmic (NC) in 10 cases and nuclear predominant (NP) in 9 cases and negative in 30 cases. CP expression cases showed a higher grade of hepatitis activity than NP expression cases. Serum HBV DNA levels showed a wide range and there was no significant difference according to the expression pattern of HBcAg. Cell proliferation activity of hepatocytes, measured by Ki-67 (MIB-1) labelling index was higher in CP expression cases than in NP expression cases and it was also significantly higher in cases of high grade than in low grade hepatitis activity. The precore region was evaluated by primer extension assay in 51 cases and there were 16 cases of 1896 precore mutant, 23 cases of wild type, 12 cases of mixed infection of 1896 precore mutant type and wild type. CP expression of HBcAg was significantly more frequent in 1896 precore mutant cases (86%) than in wild type cases (26%). Conclusion: CP expression of HBcAg is the major pattern of 1896 precore mutant cases and it might be involved in the severe liver injury of precore mutants. One of the mechanisms regulating CP HBcAg expression is suggested to be precore mutation of HBV as well as cell cycle of hepatocyte.

UR - http://www.scopus.com/inward/record.url?scp=0032978859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032978859&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.1999.tb00036.x

DO - 10.1111/j.1478-3231.1999.tb00036.x

M3 - Article

C2 - 10395039

AN - SCOPUS:0032978859

VL - 19

SP - 199

EP - 205

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 3

ER -